When a peptide is considered, it is done with guardrails: A clear reason for using it
Jardiance may lead to modest weight loss, an average of 3% of body weight, but its unlikely to be as effective as semaglutide
research into the role of the gut microbiome is at an early stage and is not yet used clinically to guide treatment decisions Adherence to treatment: Missing doses or inconsistent injection timing may reduce efficacy Concurrent medicines: As a class effect, GLP-1 receptor agonists slow gastric emptying, which may affect the absorption timing of some oral medicines
Regarding kidney outcomes, the combination of GLP1-RAas and SGLT2is has emerged as a promising therapeutic strategy in treating people with T2D
If youre looking for a broader place to shop by benefit, the Immunity Supplements collection is a useful starting point
No, it is not FDA-approved for any use